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Background: The most commonly used cardiac imaging modalities are 2D Echo(2DE) and nuclear myocardial perfusion imaging(MPI). 
Cardiac MRI(CMR) is considered 2nd line for evaluation of chest pain, dyspnea, palpitations and syncope. Despite widespread availability, 
2DE and MPI have inherent limitations that may lead to further testing. This study assessed the economic impact and clinical outcome of 
CMR for initial evaluation of cardiac symptoms.
methods: Retrospective electronic medical records were queried for new patients presenting to a hospital-based Cardiology group with 
symptoms of chest pain, shortness of breath, palpitations or syncope. Each patient was followed for > 1 year, after categorization by initial 
imaging modality, to quantify additional cardiac tests performed during the subsequent year. Initial imaging decisions were at the discretion 
of the attending cardiologist. Patients who underwent initial CMR were compared to patients who had initial 2DE or MPI. Subsequent 
cardiac tests included in the analysis were: EKG, holter monitor, EP study, non-imaging stress, MPI, stress-echo, CMR, CT angiogram , 
cardiac catherization, 2DE and TEE. Prevailing 2013 Medicare and Private Payer reimbursements were used for the analysis. The average 
economic costs for patients having undergone initial CMR versus 2DE or MPI were computed and compared using paired sample t-tests.
Major adverse cardiac events over 1 year(MACE) were computed for each group and also compared.
results: 405 patients met study inclusion criteria. 117 had an initial CMR, while 288 had initial 2DE or MPI. The average cost per patient 
with an initial CMR for Medicare was $1,842 and $3,446 for Private Insurance. The average cost per patient with an initial 2DE or MPI for 
Medicare was $7,967 and $12,344 for Private Insurance. When compared, the difference between initial CMR versus initial 2DE or MPI 
was significant for both Medicare(p<0.0019) and private insurance(p<0.0023). MACE rates were NS for the 2 groups.
conclusion:  After 1-year, patients who present with cardiac symptoms have a significantly higher cost of care if they had an initial 2DE or 
MPI, than those who had an initial CMR, with no difference in clinical outcome.
